These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2860532)

  • 1. How much of variability in apolipoprotein AII concentrations is explained by polymorphism adjacent to apo-AII gene?
    Hanis CL; Chakraborty R; Hewett-Emmett D
    Lancet; 1985 Jun; 1(8441):1339-40. PubMed ID: 2860532
    [No Abstract]   [Full Text] [Related]  

  • 2. High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man.
    Scott J; Knott TJ; Priestley LM; Robertson ME; Mann DV; Kostner G; Miller GJ; Miller NE
    Lancet; 1985 Apr; 1(8432):771-3. PubMed ID: 2858663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal localization of the human apoprotein CI gene and of a polymorphic apoprotein AII gene.
    Knott TJ; Eddy RL; Robertson ME; Priestley LM; Scott J; Shows TB
    Biochem Biophys Res Commun; 1984 Nov; 125(1):299-306. PubMed ID: 6095840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AII and coronary artery disease.
    Breier C; Drexel H; Mühlberger V; Lisch HJ; Knapp E; Braunsteiner H
    Lancet; 1985 Jun; 1(8441):1339. PubMed ID: 2860531
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic factors influencing apolipoprotein AI and AII levels in a kindred with premature coronary heart disease.
    Borecki IB; Laskarzewski P; Rao DC
    Genet Epidemiol; 1988; 5(6):393-406. PubMed ID: 3145239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.
    Shelley CS; Baralle FE
    Nucleic Acids Res; 1987 May; 15(9):3801-21. PubMed ID: 3035501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.
    Han Z; Heath SC; Shmulewitz D; Li W; Auerbach SB; Blundell ML; Lehner T; Ott J; Stoffel M; Friedman JM; Breslow JL
    Am J Med Genet; 2002 Jul; 110(3):234-42. PubMed ID: 12116231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria.
    Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML
    Nephron; 1988; 50(2):112-5. PubMed ID: 3146703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid screening method for polymorphism of group A apolipoproteins.
    Harake B; Caines PS; Thibert RJ
    J Clin Lab Anal; 1992; 6(5):290-6. PubMed ID: 1403348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
    Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoprotein AII in acute pancreatitis: intriguing improvement in the prediction of fatal outcome.
    Schneider J; Meier M; Maroske D; Kaffarnik H
    Clin Chim Acta; 1988 Feb; 171(2-3):305-10. PubMed ID: 3131047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular disease.
    Kostner GM; Marth E; Pfeiffer KP; Wege H
    Eur Neurol; 1986; 25(5):346-54. PubMed ID: 3096738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ distribution of apolipoprotein gene transcripts in 6-12 week postfertilization human embryos.
    Hopkins B; Sharpe CR; Baralle FE; Graham CF
    J Embryol Exp Morphol; 1986 Sep; 97():177-87. PubMed ID: 2432145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populations.
    Pang RW; Chen B; Janus ED; Lam KS
    Chin Med J (Engl); 1997 Jun; 110(6):465-73. PubMed ID: 9594249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.
    Kraft HG; Menzel HJ; Hoppichler F; Vogel W; Utermann G
    J Clin Invest; 1989 Jan; 83(1):137-42. PubMed ID: 2521341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
    Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Kondo Y; Nakagawara A; Katsuyama T
    J Neurosci Res; 2000 Nov; 62(4):608-14. PubMed ID: 11070505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion analysis of a unique 3' splice site indicates that alternating guanine and thymine residues represent an efficient splicing signal.
    Shelley CS; Baralle FE
    Nucleic Acids Res; 1987 May; 15(9):3787-99. PubMed ID: 3108860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum HDL cholesterol and apolipoprotein AI, AII and B levels in Singapore newborns.
    Saha N; Wong HB
    Biol Neonate; 1987; 52(2):93-6. PubMed ID: 3115319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion polymorphism 5' to the human apolipoprotein AI (apo AI) gene.
    Frossard PM; Coleman RT; Protter AA; Seilhamer JJ; Funke H; Assmann G
    Nucleic Acids Res; 1986 Nov; 14(21):8694. PubMed ID: 3097620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.